Exosome derived from stem cell: A promising therapeutics for wound healing

A wound occurs when the epidermis and dermis of the skin are damaged internally and externally. The traditional wound healing method is unsatisfactory, which will prolong the treatment time and increase the treatment cost, which brings economic and psychological burdens to patients. Therefore, there is an urgent need for a new method to accelerate wound healing. As a cell-free therapy, exosome derived from stem cell (EdSC) offers new possibilities for wound healing. EdSC is the smallest extracellular vesicle secreted by stem cells with diameters of 30-150 nm and a lipid bilayer structure. Previous studies have found that EdSC can participate in and promote almost all stages of wound healing, including regulating inflammatory cells; improving activation of fibroblasts, keratinocytes, and endothelial cells; and adjusting the ratio of collagen I and III. We reviewed the relevant knowledge of wounds; summarized the biogenesis, isolation, and identification of exosomes; and clarified the pharmacological role of exosomes in promoting wound healing. This review provides knowledge support for the pharmacological study of exosomes.

Automated summary

A wound occurs when the skin's epidermis and dermis are damaged internally and externally. The traditional method of wound healing is unsatisfactory, causing extended treatment time and increased cost for patients. Therefore, there is an urgent need for a new method to accelerate wound healing. Exosome derived from stem cell (EdSC), a cell-free therapy, offers promising possibilities for wound healing by participating in various stages of the healing process.